Last reviewed · How we verify
NCT06272513: ProAct-HNC
Influencing Factors for Physical Activity in People With Head and Neck Cancer
trial in Advanced Head and Neck Squamous Cell Carcinoma in 20 participants. Completed in 30 July 2025.
30 July 2025
Quick facts
| Lead sponsor | Kantonsspital Winterthur KSW |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 20 |
| Start date | 30 March 2024 |
| Primary completion | 30 July 2025 |
| Estimated completion | 30 July 2025 |
| Sites | 1 location across Switzerland |
Conditions studied
- Advanced Head and Neck Squamous Cell Carcinoma — all drugs for Advanced Head and Neck Squamous Cell Carcinoma →
Sponsor
Kantonsspital Winterthur KSW — full company profile →
Who can join
18 and older, any sex, with Advanced Head and Neck Squamous Cell Carcinoma. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this qualitative study is to explore influencing factors for physical activity (PA) participation in people affected by an advanced head and neck cancer from the perspective of people affected and their significant others. Individual interviews will be conducted with people affected by head and neck cancer and focus group interviews will be held with significant others of people being affected to answer the following research questions: * What capabilities and opportunities for physical activity participation do people with advanced head and neck cancer experience? * What motivates people with advanced head and neck cancer to be physically active? * What are recommendations and suggestions for a future physical activity promotion intervention? * How do significant others view capabilities, opportunities, and motivation for physical activity participation and promotion in people with head and neck cancer? The interviews will be transcribed verbatim and analysed with a structuring content analysis approach.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06272513
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Advanced Head and Neck Squamous Cell Carcinoma
Currently open trials in the same condition.
- NCT07094685 — Ivonescimab Before Surgery for the Treatment of Resectable Stage II-IV Head and Neck Cancer · Phase 2 · recruiting
- NCT04533750 — Testing the Addition of M3814 (Peposertib) to Radiation Therapy for Patients With Advanced Head and Neck Cancer Who Cann · Phase 1 · active not recruiting
- NCT05039801 — IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors · Phase 1 · recruiting
- NCT02955290 — CIMAvax Vaccine, Nivolumab, and Pembrolizumab in Treating Patients With Advanced Non-small Cell Lung Cancer or Squamous · Phase 1, PHASE2 · active not recruiting
Other Kantonsspital Winterthur KSW trials
Trials by the same sponsor.
- NCT06864117 — Urodynamics: Prone Vs. Seated Position · NA · not yet recruiting
- NCT06384053 — Skin Cancer and Hyperthermia and Radiotherapy · NA · recruiting
- NCT06135402 — Comparison of Laser Treatment With Clobetasol Therapy in Patients With Lichen Sclerosus · NA · recruiting
- NCT06643325 — Gastric Emptying Time in Traumatic Injuries · recruiting
- NCT05709717 — Regenerative Therapy With Autologous Stromal Vascular Fraction Derived Mesenchymal Stem Cells and Platelet-rich Plasma t · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06272513 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Kantonsspital Winterthur KSW
- Last refreshed: 29 August 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06272513.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing